These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33531640)

  • 1. The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer.
    Basu NN; Hodson J; Chatterjee S; Gandhi A; Wisely J; Harvey J; Highton L; Murphy J; Barnes N; Johnson R; Barr L; Kirwan CC; Howell S; Baildam AD; Howell A; Evans DG
    Sci Rep; 2021 Feb; 11(1):2847. PubMed ID: 33531640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-reducing mastectomy for the prevention of primary breast cancer.
    Carbine NE; Lostumbo L; Wallace J; Ko H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD002748. PubMed ID: 29620792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.
    Mai PL; Lagos VI; Palomares MR; Weitzel JN
    Ann Surg Oncol; 2008 Dec; 15(12):3415-21. PubMed ID: 18836779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy.
    Dettwyler SA; Thull DL; McAuliffe PF; Steiman JG; Johnson RR; Diego EJ; Mai PL
    Breast Cancer Res Treat; 2022 Jul; 194(2):393-401. PubMed ID: 35596825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
    Evans DG; Ingham SL; Baildam A; Ross GL; Lalloo F; Buchan I; Howell A
    Breast Cancer Res Treat; 2013 Jul; 140(1):135-42. PubMed ID: 23784379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral Risk-Reducing Mastectomy in Breast Cancer Patients Who Undergo Multigene Panel Testing.
    Murphy BL; Yi M; Arun BK; Gutierrez Barrera AM; Bedrosian I
    Ann Surg Oncol; 2020 Nov; 27(12):4613-4621. PubMed ID: 32720048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.
    Raphael J; Verma S; Hewitt P; Eisen A
    J Genet Couns; 2016 Dec; 25(6):1309-1316. PubMed ID: 27228984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
    Kiely BE; Jenkins MA; McKinley JM; Friedlander ML; Weideman P; Milne RL; McLachlan SA; Hopper JL; Phillips KA
    Breast Cancer Res Treat; 2010 Apr; 120(3):715-23. PubMed ID: 19669874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
    Heemskerk-Gerritsen BA; Rookus MA; Aalfs CM; Ausems MG; Collée JM; Jansen L; Kets CM; Keymeulen KB; Koppert LB; Meijers-Heijboer HE; Mooij TM; Tollenaar RA; Vasen HF; ; Hooning MJ; Seynaeve C
    Int J Cancer; 2015 Feb; 136(3):668-77. PubMed ID: 24947112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect.
    Liede A; Cai M; Crouter TF; Niepel D; Callaghan F; Evans DG
    Breast Cancer Res Treat; 2018 Sep; 171(2):435-442. PubMed ID: 29808287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
    Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
    BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
    Yoshimura A; Okumura S; Sawaki M; Hattori M; Ishiguro J; Adachi Y; Kotani H; Gondo N; Kataoka A; Iwase M; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Takaiso N; Hyodo I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):539-546. PubMed ID: 29520501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global celebrities' effect on health awareness among Jordanians: A study using the case of Angelina Jolie.
    Al-Hussaini M; Ammar K; Kasasbeh N; Sultan H; Al-Omari A
    J Genet Couns; 2019 Oct; 28(5):1021-1028. PubMed ID: 31386265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer.
    Steadman JA; Hoskin TL; Klassen C; Boughey JC; Degnim AC; Piltin MA; Mrdutt MM; Johnson JE; Hieken TJ
    Surgery; 2024 Mar; 175(3):677-686. PubMed ID: 37863697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Angelina effect: immediate reach, grasp, and impact of going public.
    Borzekowski DL; Guan Y; Smith KC; Erby LH; Roter DL
    Genet Med; 2014 Jul; 16(7):516-21. PubMed ID: 24357847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
    Evans DG; Barwell J; Eccles DM; Collins A; Izatt L; Jacobs C; Donaldson A; Brady AF; Cuthbert A; Harrison R; Thomas S; Howell A; ; ; Miedzybrodzka Z; Murray A
    Breast Cancer Res; 2014 Sep; 16(5):442. PubMed ID: 25510853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
    Jakub JW; Peled AW; Gray RJ; Greenup RA; Kiluk JV; Sacchini V; McLaughlin SA; Tchou JC; Vierkant RA; Degnim AC; Willey S
    JAMA Surg; 2018 Feb; 153(2):123-129. PubMed ID: 28903167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celebrity Health Announcements and Online Health Information Seeking: An Analysis of Angelina Jolie's Preventative Health Decision.
    Dean M
    Health Commun; 2016; 31(6):752-61. PubMed ID: 26574936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
    Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
    J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.